Novel Intervention for Drug Use and HIV Risk Among Anxiety Sensitive Heroin Users
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Anxiety Sensitivity Index-3
Study Overview
Brief Summary
Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •exhibit a score of 21 on a self-report measure of anxiety sensitivity
- •be in 28 days of residential substance use treatment.
- •meet criteria for current opioid dependence as determined by SCID interview administered at intake.
Exclusion Criteria
- •evidence of limited mental competency
- •the inability to give informed, voluntary, written consent to participate
- •current psychosis
- •current bipolar disorder.
Outcomes
Primary Outcomes
Anxiety Sensitivity Index-3
Time Frame: 24 weeks
Secondary Outcomes
- Timeline Follow Back 90 days(24 weeks)
Investigators
Joe Smith
Director - HRPP (C. Lejuez is no longer at UMD)
University of Maryland, College Park
